Assay-aware flow-cytometric interpretation of relapsed B-cell precursor acute lymphoblastic leukemia after sequential CD19- and CD22-directed therapy: A case report

Fangxiong Zheng, Juan Dong, Xiaocui Cao, Shuangzhe Li, Tengfei Ma, Jiayi Li, Jinxi Wang, Yuchen Zhang, Zhongxin Lu

Open source

DOI
10.1097/md.0000000000051427
Published
2026-11-06
Container
Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000051427,
  title = {Assay-aware flow-cytometric interpretation of relapsed B-cell precursor acute lymphoblastic leukemia after sequential CD19- and CD22-directed therapy: A case report},
  author = {Fangxiong Zheng and Juan Dong and Xiaocui Cao and Shuangzhe Li and Tengfei Ma and Jiayi Li and Jinxi Wang and Yuchen Zhang and Zhongxin Lu},
  year = {2026},
  journal = {Medicine},
  doi = {10.1097/md.0000000000051427},
  url = {https://doi.org/10.1097/md.0000000000051427}
}

RIS

TY  - JOUR
TI  - Assay-aware flow-cytometric interpretation of relapsed B-cell precursor acute lymphoblastic leukemia after sequential CD19- and CD22-directed therapy: A case report
AU  - Fangxiong Zheng
AU  - Juan Dong
AU  - Xiaocui Cao
AU  - Shuangzhe Li
AU  - Tengfei Ma
AU  - Jiayi Li
AU  - Jinxi Wang
AU  - Yuchen Zhang
AU  - Zhongxin Lu
PY  - 2026
JO  - Medicine
DO  - 10.1097/md.0000000000051427
UR  - https://doi.org/10.1097/md.0000000000051427
ER  - 

APA

Zheng, F., Dong, J., Cao, X., Li, S., Ma, T., Li, J., Wang, J., Zhang, Y., & Lu, Z. (2026). Assay-aware flow-cytometric interpretation of relapsed B-cell precursor acute lymphoblastic leukemia after sequential CD19- and CD22-directed therapy: A case report. Medicine. https://doi.org/10.1097/md.0000000000051427

Source records